Journal
BEHAVIOURAL PHARMACOLOGY
Volume 22, Issue 5-6, Pages 390-404Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/FBP.0b013e328349aae4
Keywords
5-hydroxytryptamine; 5-hydroxytryptamine receptors; chronic pain; descending inhibition or facilitation; peripheral
Ask authors/readers for more resources
Serotonin [5-hydroxytryptamine (5-HT)] in the central nervous system and in the periphery has long been considered to have an important role in the control of pain, for example, through descending inhibition. In recent years, considerable research efforts have focused on the role played by 5-HT on acute or chronic pain states as well as on the identification of the respective 5-HT receptors involved. However, preclinical studies have reported conflicting observations, and numerous important questions remain unanswered. The purpose of this study is to provide an analysis of the recent developments in understanding the role of 5-HT both within the periphery and at the level of the spinal dorsal horn. We discuss the inhibitory or facilitatory influences exerted by 5-HT, through the descending 5-HT pathway, on spinal processing of nociceptive information in pathological pain states. Evidence with regard to the possible implication of the 5-HT1A, 5-HT2A, 5-HT3, and 5-HT7 receptors in pain modulation is also reviewed. Recent studies (both behavioral and clinical, relevant to these targets) have indeed demonstrated that 5-HT1A and 5-HT7 receptor agonists or 5-HT2A and 5-HT3 receptor antagonists may be promising therapeutic agents for the treatment of pain states. Behavioural Pharmacology 22:390-404 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available